Goldman Sachs’s uniQure QURE Stock Holding History

Goldman Sachs’s Portfolio QURE Stock Details QURE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-60,000	Closed	-$836K	–	6602
2025 Q2	$836K	Buy	60,000 +2,000	+3%	+$26.9K	﹤0.01%	4824
2025 Q1	$615K	Hold	58,000	–	–	﹤0.01%	5061
2024 Q4	$1.02M	Buy	+58,000	New	+$501K	﹤0.01%	4809
2021 Q2	–	Sell	-28,900	Closed	-$974K	–	6459
2021 Q1	$974K	Sell	28,900 -18,700	-39%	-$670K	﹤0.01%	4636
2020 Q4	$1.72M	Sell	47,600 -12,000	-20%	-$506K	﹤0.01%	3831
2020 Q3	$2.19M	Buy	+59,600	New	+$2.44M	﹤0.01%	3499
2020 Q1	–	Sell	-7,200	Closed	-$516K	–	5504
2019 Q4	$516K	Buy	+7,200	New	+$395K	﹤0.01%	4485
2016 Q1	–	Sell	-29,900	Closed	-$495K	–	7274
2015 Q4	$495K	Sell	29,900 -73,000	-71%	-$1.35M	﹤0.01%	4928
2015 Q3	$2.1M	Buy	+102,900	New	+$2.71M	﹤0.01%	3739

Other funds holding QURE

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return

Goldman Sachs's QURE Position: Q1 2026 in Review

Goldman Sachs increased its uniQure (QURE) stake by 8.2% in Q1 2026, buying an estimated $1.94M and bringing the position to 1,263,236 shares worth $20.7M. The position accounts for ﹤0.01% of the portfolio, ranked #2405.

Goldman Sachs first reported a position in QURE in Q3 2015 and has held it in 40 quarters since. The position peaked at $38.7M in Q3 2025. 212 funds tracked by Wall St. Rank hold QURE as of Q1 2026.

Goldman Sachs held 1,263,236 shares of uniQure worth $20.7M as of Q1 2026.
Goldman Sachs bought 95,628 uniQure shares in Q1 2026, an estimated $1.94M.
uniQure made up ﹤0.01% of Goldman Sachs's portfolio in Q1 2026, its #2405 holding.
Goldman Sachs first reported a position in uniQure in Q3 2015 and has held it in 40 quarters since.
Goldman Sachs's uniQure position peaked at $38.7M in Q3 2025.
212 funds tracked by Wall St. Rank held uniQure as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.